Does anyone have any feelings for Yule Catto?

I sold short on CFD a few weeks back but now they seem to be on the way back up.
They seem to be building support at 240 and are testing the 270.

If any has any opinions on which way they're heading, I greatly appreciate.

Graham

StockMarketWire.com
Chemicals group Yule Catto & Co plc delivered a 19% improvement in underlying pre-tax profit for the year to December with a further substantial reduction in its net debt.

Profit before tax and special items rose to 47.0m from 39.6m.

Total sales increased by 21% to 645.8m, driven mainly by the recovery of input price increases and volume gains in the Polymer business.

Earnings per share were up 22% at 16.2p from 13.3p.

Net debt fell to 63m from 88m.

The group resumed its final dividend with a payment of 1.3p a share, after returning to the dividend list with an interim payment of 2p.

CEO Adrian Whitfield said the highlight of the year was the transformational acquisition of PolymerLatex announced in December, which would substantially increase the group's scale and growth opportunities. Eventual annual cost synergies of 20m were expected.

The group's core business of Polymers accounted for 85% of revenue in 2010 and 88% of divisional operating profits. Volumes were ahead in most areas of the business and operating profit increased by 10% to 56.7m.

In the Pharma division, business started slowly with a weak first quarter but performance improved during the year. Full year operating profit was 1.1m below the prior year and the business now represented just 10% of group revenue.

The one remaining Impact business, William Blythe, continued to improve, generating 3.5m of operating profit.

Numis has downgraded YC to hold with TP 223

StockMarketWire.com
Yule Catto upgraded to buy from add at Brewin Dolphin, target price stays 270p.

Morgan Stanley: overweight, TP 285

Midas share tips


Buy Yule Catto at 199p - Yule Catto shares have
dropped to 199p since announcing its 2010 figures
on March 9. But the firm is able to pass price
rises on to customers and the PolymerLatex deal
should help compensate for slow European growth by
selling more in Asia. The shares are likely to start
moving up in the next few months. Buy.

RBS says: Buy. TP upped: 260 from 250

error

YC: BarCap: overweight, TP cut to 263 from 300

Brokers ALL backing YULC...

EPS growth of 27.6% pencilled in for 2012 Forward P/E of just over 9... derd cheap and way undervalued IMO.


Yule Catto & Co PLC

FORECASTS 2011 2012
Date Rec Pre-tax () EPS (p) DPS (p) Pre-tax () EPS (p) DPS (p)

Brewin Dolphin
19-04-11 BUY 81.60 17.40 2.60 113.60 24.00 3.00
The Royal Bank of Scotland NV
18-04-11 BUY 54.71 17.72 5.99 63.81 20.67 6.99
Altium Securities
11-03-11 BUY 90.80 20.00 3.00 113.40 25.00 4.00
Numis Securities Ltd
11-03-11 BUY 85.60 18.30 2.75 113.40 24.40 2.90
Collins Stewart [R]
11-11-10 BUY 17.25 18.54

2011 2012
Pre-tax () EPS (p) DPS (p) Pre-tax () EPS (p) DPS (p)

Consensus 77.38 18.24 3.63 100.23 23.27 4.26
1 Month Change -8.54 -0.31 0.85 -13.24 -1.19 0.97
3 Month Change 1.89 1.35 -0.11 6.79 5.04 -0.76


GROWTH
2010 (A) 2011 (E) 2012 (E)

Norm. EPS 18.14% -0.24% 27.60%
DPS % 178.92% 17.60%

INVESTMENT RATIOS
2010 (A) 2011 (E) 2012 (E)

EBITDA 64.82m 109.58m 133.81m
EBIT 50.20m m m
Dividend Yield 0.60% 1.68% 1.97%
Dividend Cover 14.06x 5.03x 5.46x
PER 11.82x 11.84x 9.28x
PEG 0.65f -50.06f 0.34f
Net Asset Value PS -5.32p 52.80p 66.52p

Ex-divi date is the 8th June 2011 (1.3p)

StockMarketWire.com
Chemical group Yule Catto & Co plc said in its IMS that earnings for the first quarter were well ahead of the same period last year, excluding any impact of the PolymerLatex acquisition in March.

The board's expectations for financial performance for 2011 remain unchanged.

Overall demand in Yule Catto's Polymer business was solid. Asian demand was strong through the quarter, while Europe firmed after a slow start in the UK.

PolymerLatex had traded comfortably ahead of last year in the first quarter and this had continued through April.

The group remained confident that at least 20m of synergies would be delivered. Actions taken to date had already delivered synergies with an annual run rate value of about 2m.

In the group's other businesses, the Pharma division performed well ahead of a weak Q1 last year, while William Blythe continued to grow profits strongly.

Numis: has moved YULC to add from buy. TP 244p.

Hoping the sp moves firmly through the 200 DMA.

JPMorgan: Reiterated overweight - TP raised to 300 from 268

Looking better now and the latest brokers' positive forecasts
have probably helped as well

The latest, this one from Deutsche: Initiated buy - TP 290

Seems only HC and I are interested around here.

no - there are other interested parties but sometimes there's simply nothing to say other than sit back and be patient.

Questor in the Sunday Telegraph says 'Buy':

http://www.telegraph.co.uk/finance/markets/questor/8569182/Questor-share-tip-Buy-Yule-Catto-as-its-markets-bounce-back.html

200 DMA now coming up! Steady up trend for now.
EDIT: Couldn't break through!

Sailed through and I sold last week! :o(

Its easy this game :-)